Literature DB >> 17158548

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

Ulrich Halm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17158548     DOI： 10.1200/JCO.2006.08.4798

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.

Authors:  Yueming Zhang; Yaolin Xu; Dansong Wang; Tiantao Kuang; Wenchuan Wu; Xuefeng Xu; Dayong Jin; Wenhui Lou
Journal:  Int J Clin Oncol       Date:  2020-09-21       Impact factor: 3.402

Review 2.  Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification.

Authors:  Annie H Ren; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Mol Cell Proteomics       Date:  2021-09-28       Impact factor: 7.381

3.  Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy.

Authors:  Ningyi Ma; Zheng Wang; Jiandong Zhao; Jiang Long; Jin Xu; Zhigang Ren; Guoliang Jiang
Journal:  Med Sci Monit       Date:  2017-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.